Clinical Trials
2 trialsNCT02142335 2014-05-20
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
California Cancer Assocaties for Research & Excellence
Phase 2 Unknown
NCT00409383 2011-11-07
Abraxane and Temodar Plus Genasense in Advanced Melanoma
Genta Incorporated
Phase 1 Unknown